{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:34:15Z","timestamp":1771954455175,"version":"3.50.1"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T00:00:00Z","timestamp":1408492800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0104763","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T18:07:45Z","timestamp":1408558065000},"page":"e104763","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["GBA2-Encoded \u03b2-Glucosidase Activity Is Involved in the Inflammatory Response to Pseudomonas aeruginosa"],"prefix":"10.1371","volume":"9","author":[{"given":"Nicoletta","family":"Loberto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maela","family":"Tebon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Lampronti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Aureli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaria","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Giri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentino","family":"Bezzerri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Lovato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Cant\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Munari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng H.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Cavazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gambari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Sonnino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Cabrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Dechecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,8,20]]},"reference":[{"key":"ref1","unstructured":"Welsh JM, Ramsey BW, Accurso F, Cutting GR (2001) Cystic Fibrosis in Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). <italic>The Metabolic and Molecular Bases of Inherited Diseases<\/italic>. McGraw-Hill, New York."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"VX08-770-102 Study Group A CFTR Potentiator in Patients with Cystic Fibrosis and the <italic>G551D<\/italic> Mutation","volume":"365","author":"BW Ramsey","year":"2011","journal-title":"New England J of Medicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.12-1639","article-title":"Cystic Fibrosis Therapeutics. The road ahead","volume":"143(1)","author":"LR Hoffman","year":"2013","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.200702-181OC","article-title":"Clinical use of Ibuprofen is associated with slower Fev1 decline in children with cystic fibrosis","volume":"(11)","author":"MW Konstan","year":"2007","journal-title":"Am J Respir Crit Care Med 176"},{"key":"ref5","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"TZ Khan","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/infdis\/175.3.638","article-title":"Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis","volume":"175","author":"TL Noah","year":"1997","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1165\/ajrcmb.23.2.4214","article-title":"Inflammation and infection in naive human cystic fibrosis airway grafts","volume":"23(2)","author":"R Tirouvanziam","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1385\/CRIAI:23:1:005","article-title":"The role of inflammation in the pathophysiology of CF lung disease","volume":"23","author":"JF Chmiel","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s00018-007-7076-0","article-title":"The metabolism and function of shingolipids and glycoshingolipids","volume":"64","author":"S Lahiri","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1164\/rccm.200804-595SO","article-title":"Sphingolipids in the lungs","volume":"178(11)","author":"S Uhlig","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1753465811406772","article-title":"The role of sphingolipids in respiratory disease","volume":"5","author":"Y Yang","year":"2001","journal-title":"Ther Adv Respir Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"YA Hannun","year":"2008","journal-title":"Nat Rew Mol Cell Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm823","article-title":"Host defense against <italic>Pseudomonas aeruginosa<\/italic> requires ceramide-rich membrane rafts","volume":"9","author":"H Grassme\u2019","year":"2003","journal-title":"Nature Medicine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm1748","article-title":"Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis","volume":"14","author":"V Teichgraber","year":"2008","journal-title":"Nature Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1165\/rcmb.2007-0036OC","article-title":"Fenretinide corrects newly found ceramide deficiency in cystic fibrosis","volume":"38(1)","author":"C Guilbault","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1165\/rcmb.2008-0295OC","article-title":"Defective acid sphingomyelinase pathway with <italic>Pseudomonas aeruginosa<\/italic> infection in cystic fibrosis","volume":"41","author":"H Yu","year":"2009","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1164\/rccm.200905-0799OC","article-title":"Ceramide is Increased in the Lower Airway Epithelium of People with Advanced Cystic Fibrosis Lung Disease","volume":"(3)","author":"M Brodlie","year":"2010","journal-title":"Am J Respir Crit Care Med 182"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4049\/jimmunol.1002850","article-title":"Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema","volume":"186","author":"M Bodas","year":"2011","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1159\/000350071","article-title":"Therapy of CF-patients with amitriptyline and placebo-a randomised, double-blind, placebo-controlled phase IIb multicenter, cohort-study","volume":"31(4\u20135)","author":"L N\u00e4hrlich","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1165\/rcmb.2010-0457OC","article-title":"Modulators of sphingolipid metabolism reduce lung inflammation","volume":"45(4)","author":"MC Dechecchi","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbagen.2013.10.018","article-title":"Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis","volume":"1840(1)","author":"A Caretti","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"ref22","first-page":"1","article-title":"Iminosugars as therapeuthic agents:recent advances and promising trends","volume":"3(12)","author":"RJ Nash","year":"2011","journal-title":"Future Med Chem"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Dechecchi MC, Nicolis E, Mazzi P, Paroni M, Cioffi F, <etal>et al<\/etal>.. (2012) Pharmacological modulators of sphingolipid metabolism for the treatment of cystic fibrosis lung inflammation. In Dinesh D and Sriramulu D editors. Cystic Fibrosis - the Human Agony, ISBN 979-953-307-059-8, Germany.","DOI":"10.5772\/31050"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.febslet.2006.03.010","article-title":"Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the \u03b1-glucosidase inhibitor miglustat","volume":"580","author":"C Norez","year":"2006","journal-title":"FEBS Lett"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jcf.2008.06.002","article-title":"Anti-inflammatory effect of miglustat in bronchial epithelial cells","volume":"7(6)","author":"MC Dechecchi","year":"2008","journal-title":"J Cyst Fibros"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.200901-0049OC","article-title":"Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice","volume":"179","author":"B Lubamba","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcf.2011.12.004","article-title":"A randomized placebo-controlled trial of miglustat in cystic fibrosi based on nasal potential difference","volume":"11(3)","author":"A Leonard","year":"2012","journal-title":"J Cystic Fibrosis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0304-3835(87)90196-0","article-title":"Antitumor activity via inhibition of glycosphingolipid biosynthesis","volume":"38","author":"J Inokuchi","year":"1987","journal-title":"Cancer Lett"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1074\/jbc.M610544200","article-title":"Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2","volume":"282","author":"RG Boot","year":"2007","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"26052","DOI":"10.1074\/jbc.M113.463562","article-title":"\u03b2-Glucosidase 2 (GBA2) activity and imino sugar pharmacology","volume":"288(36)","author":"CM Ridley","year":"2013","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrd708","article-title":"Targeting glycosylation as a therapeutic approach","volume":"1","author":"RA Dwek","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"27108","DOI":"10.1016\/S0021-9258(18)47132-3","article-title":"N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing","volume":"(43)","author":"FM Platt","year":"1994","journal-title":"J Biol Chem 269"},{"key":"ref33","first-page":"689","article-title":"Large-Scale synthesis of the glucosylceramide synthase inhibitor N-[5-(Adamantan-1-yl-methoxy)-pentyl]-1-deoxynojirimycin","volume":"53","author":"T Weenekes","year":"2010","journal-title":"J Med Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"26522","DOI":"10.1074\/jbc.273.41.26522","article-title":"Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase","volume":"(41)","author":"HS Overkleeft","year":"1998","journal-title":"J Biol Chem 273"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility","volume":"116","author":"Y Yildiz","year":"2006","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/db06-1619","article-title":"Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity","volume":"56(5)","author":"JM Aerts","year":"2007","journal-title":"Diabetes"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1165\/ajrcmb\/4.4.313","article-title":"A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection","volume":"4","author":"PL Zeitlin","year":"1991","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"L844","DOI":"10.1152\/ajplung.00355.2002","article-title":"Development of cystic fibrosis and non cystic fibrosis airway cell lines","volume":"284","author":"J Zabner","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1113\/jphysiol.2012.240838","article-title":"Association of TMEM16A chloride channel overexpression with airway goblet cell metaplasia","volume":"(23)","author":"P Scudieri","year":"2012","journal-title":"J Physiol 590"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0076-6879(07)32004-1","article-title":"Structure-specific, quantitative methods for analysis of sphingolipids by LC-tandem MS: \u201cinside-out\u201d sphingolipids","volume":"432","author":"MC Sullards","year":"2007","journal-title":"Methods in Enzymology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s11064-012-0725-1","article-title":"Plasma membrane-associated glycohydrolases activation by extracellular acidification due to proton exchangers","volume":"37(6)","author":"M Aureli","year":"2012","journal-title":"Neurochem Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"19365","DOI":"10.1074\/jbc.272.31.19365","article-title":"Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with <italic>N<\/italic>- butyldeoxynojirimycin","volume":"272","author":"FM Platt","year":"1996","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajhg.2012.11.021","article-title":"Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia","volume":"92(2)","author":"E Martin","year":"2013","journal-title":"Am J Hum Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1096\/fj.12-215152","article-title":"The nonlysosomal \u03b2-glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells","volume":"27(2)","author":"SC Sorli","year":"2013","journal-title":"FASEB J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1074\/jbc.M112.414714","article-title":"The non-lysosomal \u03b2-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi","volume":"288(5)","author":"HG K\u00f6rschen","year":"2013","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/imm.12122","article-title":"Acute infection of mice with Clostridium difficile leads to eIF2\u03b1 phosphorylation and pro-survival signalling as part of the mucosal inflammatory response","volume":"140(1)","author":"AA Sadighi Akha","year":"2013","journal-title":"Immunology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/pds.1779","article-title":"Miglustat (Zavesca) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme","volume":"18(9)","author":"CE Hollak","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref48","first-page":"1","article-title":"Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease","volume":"6(6)","author":"KM Ashe","year":"2011","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0104763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T03:49:01Z","timestamp":1649994541000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0104763"}},"subtitle":[],"editor":[{"given":"Dominik","family":"Hartl","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,20]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0104763","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,20]]}}}